- Home
- Applications
- europe
- patient blood
Refine by
Patient Blood Product Applications In Europe
2 applications found
We adapted an autologous ex-vivo gene therapy method to load the patient’s own TEMs precursors, that are hematopoietic stem and progenitor cells (HSPCs), with an immunotherapeutic transgene sequence. By re-introducing gene-modified HSPCs into the patient, we seek to take advantage of the self-renewing and multi-differentiation capability of HSPCs to enable durable and potentially long-term effects following a single ...
ByGenenta Science based in Milano, ITALY
The treatment differs according to the severity of the haemophilia, which is classified as mild, moderate or severe, depending on how much clotting factor is still detectable in the patient’s blood. Most patients have severe haemophilia A (residual activity of factor VIII less than ...
ByBiotest AG based in Dreieich, GERMANY